In the BioHarmony Drug Report Database

"Preview" Icon

Famotidine

Fluxid, Pepcid, Pepcid Ac, Pepcid Rpd (famotidine) is a small molecule pharmaceutical. Famotidine was first approved as Fluxid on 1986-10-15. It is used to treat duodenal ulcer, dyspepsia, gastroesophageal reflux, heartburn, and helicobacter infections amongst others in the USA. The pharmaceutical is active against histamine H2 receptor. Pepcid’s patent is valid until 2021-08-26 (FDA).

 

Trade Name

 

Fluxid, Pepcid, Pepcid Ac, Pepcid Rpd
 

Common Name

 

famotidine
 

ChEMBL ID

 

CHEMBL902
 

Indication

 

duodenal ulcer, dyspepsia, gastroesophageal reflux, heartburn, helicobacter infections, peptic esophagitis, stomach ulcer, urticaria, zollinger-ellison syndrome
 

Drug Class

 

H2-receptor antagonists (cimetidine type)

Image (chem structure or protein)

Famotidine structure rendering